Ives Jeffrey L.
SEC CIK 1614096 · EDGAR
BoughtSold
Most active insiders at ABOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meisner Derek M | CLO, Corp Sec | — | $248.8K |
| 2 | OConnell Daniel Joseph | CEO, Dir | — | $163.2K |
| 3 | Porter Derrell | Dir | — | $75.2K |
| 4 | Zuga Matt | CFO, Chief Business Off | — | $49.6K |
| 5 | Barton Russell | COO | — | $30.0K |
| 6 | Siemers Eric | Chief Medical Off | — | $27.1K |
| 7 | Doherty James J. | Pres, CDO | — | $15.2K |
| 8 | Fountain Nathan B | Dir | — | $14.3K |
| 9 | Schacterle Amy | Chief Regulatory Off | — | $2,172 |
| 10 | Stoppel Laura | Dir | — | — |
| 13 | Ives Jeffrey L. | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:29 | 2026-06-03 | ABOS | Acumen Pharmaceuticals, Inc. | Ives Jeffrey L. | Dir | A - Grant | $0.00 | +35.5K | 48.3K | +277% | $0 |
| D | 2025-06-05 | 2025-06-04 | ABOS | Acumen Pharmaceuticals, Inc. | Ives Jeffrey L. | Dir | A - Grant | $0.00 | +12.8K | 12.8K | New | $0 |
| D | 2024-06-06 | 2024-06-04 | TVRD | Tvardi Therapeutics, Inc. | Ives Jeffrey L. | Dir | A - Grant | $0.00 | +150.6K | 198.5K | +315% | $0 |
| DM | 2023-08-18 | 2023-08-17 | ABOS | Acumen Pharmaceuticals, Inc. | Ives Jeffrey L. | Dir | S - Sale+OE | $6.49 | -41.9K | 0 | -100% | -$272.3K |
| DM | 2023-08-18 | 2023-08-17 | ABOS | Acumen Pharmaceuticals, Inc. | Ives Jeffrey L. | Dir | M - OptEx | $0.7514 | +41.9K | 2,800 | New | +$31.5K |
| D | 2023-06-05 | 2023-06-01 | TVRD | Tvardi Therapeutics, Inc. | Ives Jeffrey L. | Dir | A - Grant | $0.00 | +32.4K | 47.8K | +209% | $0 |
| 2022-07-19 | 2022-07-15 | TVRD | Tvardi Therapeutics, Inc. | Ives Jeffrey L. | Dir | S - Sale | $9.05 | -3,600 | 15.5K | -19% | -$32.6K | |
| D | 2022-06-06 | 2022-06-02 | TVRD | Tvardi Therapeutics, Inc. | Ives Jeffrey L. | Dir | A - Grant | $0.00 | +11.9K | 19.1K | +165% | $0 |
| 2021-11-16 | 2021-11-12 | TVRD | Tvardi Therapeutics, Inc. | Ives Jeffrey L. | Dir | S - Sale | $16.04 | -8,180 | 7,200 | -53% | -$131.2K |
Purchase Sale Sale after option exercise All abbreviations